The drugmaker, best known for developing weight-loss and diabetes drugs, failed to excite investors hoping for a turnaround.

Source: [MarketWatch](https://www.marketwatch.com/story/novo-nordisk-stock-tumbles-as-ozempic-maker-sets-out-2030-goals-8a5a8d2d?mod=mw_rss_topstories)

Sponsored